Olmeda Biosciences LLC
Publicly observedSan Diego, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | San Diego | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Olmeda Biosciences LLC | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | X8JYKGL1HJ91 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant7 Sept 2026Publicly observed
NIH SBIR/STTR award: Deep Whole Genome Sequencing of Aqueous Humor cfDNA for Diagnosis of Intraocular Malignancies
USD 398,880.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant1 Aug 2025Publicly observed
NIH SBIR/STTR award: CLIA-LDT Development and Clinical Validation of anAqueous Humor-Based Multiplex Assay for Uveal Melanoma Metastatic Risk Prediction
USD 1,028,948.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant5 Sept 2024Publicly observed
NIH SBIR/STTR award: Development of a Novel Aqueous Humor-Based Multiplex Assay for Uveal Melanoma Metastatic Risk Prediction
USD 55,000.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.